Tech Center 1600 • Art Units: 1655 1656
This examiner grants 79% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18086034 | BETA-AMYLASE ENZYMES | Final Rejection | BASF SE |
| 18599588 | AUXOTROPHIC STRAINS OF STAPHYLOCOCCUS BACTERIUM | Final Rejection | Azitra Inc |
| 17567868 | METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE | Final Rejection | Research Development Foundation |
| 18393339 | Process for the Production of Fucosylated Oligosaccharides | Non-Final OA | Chr. Hansen A/S |
| 18020068 | NOVEL BACTERIAL PROTEIN FIBERS | Non-Final OA | NORWEGIAN UNIVERSITY OF LIFE SCIENCES |
| 18482262 | Highly Contracted Synthetic Fibroin Fiber, Production Method Therefor, and Method for Contracting Synthetic Fibroin Fiber | Final Rejection | Spiber Inc. |
| 17999465 | ANTIVIRAL FABRIC | Non-Final OA | AMOGREENTECH CO., LTD. |
| 17792700 | FUSION PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | Bang Ding |
| 18011073 | IMPROVED THROMBIN INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC CONDITIONS | Non-Final OA | THE HEART RESEARCH INSTITUTE LTD |
| 17365292 | METHODS FOR DESIGNING DNA BINDING PROTEIN CONTAINING PPR MOTIFS, AND USE THEREOF | Final Rejection | HIROSHIMA UNIVERSITY |
| 17403846 | Fusion Protein | Final Rejection | Viravaxx AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy